1999
DOI: 10.1002/(sici)1097-0339(199902)20:2<70::aid-dc5>3.0.co;2-e
|View full text |Cite
|
Sign up to set email alerts
|

Use of the Thin Prep� Pap Test? in clinical practice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

3
49
1

Year Published

1999
1999
2009
2009

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 74 publications
(53 citation statements)
references
References 14 publications
3
49
1
Order By: Relevance
“…There was no difference in the specificity of the 2 methods. As found in previous studies, [12][13][14][15][16][17] LBC produced a substantially smaller proportion of ''satisfactory-but-limited-by'' results (27.9% vs. 6.5%), and a significantly higher proportion of unsatisfactory results (2.2% vs. 0.8%). All unsatisfactory LBC results were due to scant cellularity, perhaps reflecting high levels of cervical atrophy in our population of older women, aged 35-65.…”
Section: Discussionsupporting
confidence: 68%
See 1 more Smart Citation
“…There was no difference in the specificity of the 2 methods. As found in previous studies, [12][13][14][15][16][17] LBC produced a substantially smaller proportion of ''satisfactory-but-limited-by'' results (27.9% vs. 6.5%), and a significantly higher proportion of unsatisfactory results (2.2% vs. 0.8%). All unsatisfactory LBC results were due to scant cellularity, perhaps reflecting high levels of cervical atrophy in our population of older women, aged 35-65.…”
Section: Discussionsupporting
confidence: 68%
“…Some previous studies have also found that LBC has a higher unsatisfactory rate, 13,[18][19][20] although others have not. 12,14,16,17,21 A number of meta-analyses and systematic reviews have assessed the results of previous studies comparing LBC and conventional cytology with differing conclusions regarding test performance depending on the study inclusion criteria. Although several have concluded, in contrast to our findings, that the accumulated evidence suggests that LBC improves the detection of high-grade disease, 7,22-24 they have also unanimously noted the dearth of high-quality research needed to adequately answer this question.…”
Section: Discussionmentioning
confidence: 99%
“…4 Recently the liquid-based Pap test has been introduced to overcome the drawbacks of the conventional Pap smear and has resulted in the reduction of limited and unsatisfactory specimens and improvement in the adequacy and detection rates for squamous intraepithelial lesions. 7 The liquid-based Pap test also has an advantage for HPV-DNA testing and immunocytochemistry in that residual liquid specimens that re- main after the cytology slide has been made can be used. In the current study, the detection of HPV subtypes was performed with PCR using DNA taken from the residual cells of liquid samples used for the liquidbased Pap smear.…”
Section: Discussionmentioning
confidence: 99%
“…6 The introduction of the Bethesda system has made the interpretation of findings more uniform and liquid-based technology has decreased the false-negative results found in cervical cytology. 7 In gynecologic cytology, many studies have shown that the liquid-based Pap test significantly increases the detection of squamous intraepithelial lesions compared with the conventional Pap test. 8 Conversely, it is well known that human papillomavirus (HPV) infection plays a crucial role in the development of various preneoplastic and neoplastic cervical lesions and the progression of these lesions largely depends on the infection of high-risk HPV subtypes such as HPV-16, HPV-18, HPV-31,etc.…”
mentioning
confidence: 99%
“…Recent clinical series (1)(2)(3) have suggested that the ThinPrep PapTest™ (Cytyc Corporation, Boxborough, Massachusetts) is more sensitive than the traditional Pap smear for the detection of cervical squamous intraepithelial lesions (SIL). In addition, the ThinPrep Pap test has the added benefit that a residual sample, especially in problematic cases, can be used to test for human papillomavirus (HPV) DNA using the Hybrid Capture II technique (4).…”
mentioning
confidence: 99%